Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ocular Therapeutix (OCUL) Retained Earnings: 2013-2024

Historic Retained Earnings for Ocular Therapeutix (OCUL) over the last 12 years, with Dec 2024 value amounting to -$891.1 million.

  • Ocular Therapeutix's Retained Earnings fell 29.63% to -$1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.1 billion, marking a year-over-year decrease of 29.63%. This contributed to the annual value of -$891.1 million for FY2024, which is 27.74% down from last year.
  • Latest data reveals that Ocular Therapeutix reported Retained Earnings of -$891.1 million as of FY2024, which was down 27.74% from -$697.6 million recorded in FY2023.
  • In the past 5 years, Ocular Therapeutix's Retained Earnings registered a high of -$539.3 million during FY2020, and its lowest value of -$891.1 million during FY2024.
  • Over the past 3 years, Ocular Therapeutix's median Retained Earnings value was -$697.6 million (recorded in 2023), while the average stood at -$735.2 million.
  • Data for Ocular Therapeutix's Retained Earnings shows a maximum YoY plummeted of 40.57% (in 2020) over the last 5 years.
  • Over the past 5 years, Ocular Therapeutix's Retained Earnings (Yearly) stood at -$539.3 million in 2020, then declined by 1.22% to -$545.8 million in 2021, then fell by 13.02% to -$616.8 million in 2022, then fell by 13.09% to -$697.6 million in 2023, then dropped by 27.74% to -$891.1 million in 2024.